Virginia Tech researchers have shown that memory loss in aging may be reversible. Using CRISPR tools, they corrected molecular disruptions in the hippocampus and amygdala, restoring memory in older ...

A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...

Cathy Tie, who launched her first biotech in SF's IndieBio, now leads Manhattan Genomics in controversial push to edit human ...

Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...

With $80 million in funding from a list of high-profile backers, the startup is developing bifunctional antibodies that drag ...

To solve this critical challenge, he founded Nephrogen in 2022, a biotech startup that uses AI and advanced screening to ...

Researchers have identified molecular mechanisms behind age-related memory decline — and shown they can be reversed.

Both CRSP and NTLA are advancing in vivo gene editing therapies targeting large markets, with financial stability supporting ...

I'm curious to see some of the receivers who will be used in Fantasy lineups in Week 7, especially in deeper formats. While CeeDee Lamb (ankle) and Mike Evans (hamstring) might return to action after ...

Israel and Hamas began negotiating the second phase of a plan outlined by President Trump to end the war in Gaza, as debates continued about the militant group’s failure to return all the bodies of ...

An artificial intelligence startup called Viven is pitching the idea of digital twins of enterprise employees that can aid in collaboration after raising $35 million in seed funding. The round, ...

Electric aviation startup Beta Technologies has priced shares for its initial public offering between $27 and $33, in hopes of raising as much as $825 million, according to a regulatory document filed ...